1. History
Established in 2011.
2. Honors & Accreditations
Founding Unit, Breast Disease Professional Committee, ShenzhenAssociation of Traditional Chinese Medicine
Lead Unit, Thyroid and Breast Specialty Group, Shenzhen TCMSurgery Quality Control Center
Core Member, Lingnan Breast Disease Integrated TCM–WesternMedicine Alliance
Core Member, Shenzhen–Dongguan–Huizhou Breast Specialist Alliance
Member, Shenzhen Thyroid Disease Prevention and Treatment Alliance
Member, Shenzhen Breast Tumor Plastic Surgery and ReconstructionAlliance
3. Leadership
Professor Han Bingsheng served as the founding administrativedirector, laying the groundwork for the department's development. Since 2015,Professor Li Zhixin has led the department, driving its academic and clinicalexpansion.
4. Clinical Focus
We specialize in the integrated TCM–Western diagnosis,treatment, research, and education of:
Benign and malignant breast tumors
Benign and malignant thyroid tumors
Benign breast hyperplastic diseases
Breast inflammatory diseases
5. Operations & Capacity
6. Specialty Clinics
We operate dedicated clinics for:
Thyroid nodules
Breast nodules
Breast cancer early screening
Mastalgia
Nipple discharge
Lactational mastitis
Granulomatous mastitis
Postoperative TCM rehabilitation for oncology patients
7. External Collaboration
To elevate clinical and research standards, we have partnered withthe Department of Breast Surgery at Guilin Hospital of Traditional ChineseMedicine—a national key clinical discipline and the first center in China toachieve ESMO certification for breast cancer care.
8. Surgical Capabilities
Diagnostic & Minimally Invasive
Core needle and fine-needle aspiration biopsy (breast/thyroid)
Vacuum-assisted minimally invasive excision (breast)
Microwave and radiofrequency ablation (breast/thyroid)
Oncologic Breast Surgery
Breast-conserving oncoplastic surgery
Sentinel lymph node biopsy
Radical mastectomy with prosthetic or autologous reconstruction
Endoscopic breast-conserving and reconstructive procedures
Thyroid Surgery
Open radical thyroidectomy
Endoscopic radical thyroidectomy
Signature Innovation: Immediate Latissimus Dorsi Fat FlapReconstruction
We were among the first in China to perform subcutaneous radicalmastectomy with immediate latissimus dorsi fat flap breast reconstruction—achievingoncologic radicality while preserving aesthetic outcomes. >500 casesperformed to date, representing a leading national volume.
9. TCM Integration & Research
Core Pathogenesis Theory
Professor Li Zhixin, drawing on 20 years of clinical experience,has articulated the central TCM pathogenesis of thyroid and breast disorders as"wood stagnation, earth dampness, and water cold" (木郁土湿水寒).Based on syndrome differentiation, he developed the core formula Jianpi YishenSanjie Decoction (健脾益肾散结汤) to regulate constitutionalimbalances and prevent nodule formation.
10. Center of Excellence: Granulomatous Mastitis
This is our dominantspecialty disease with a comprehensive multimodal protocol:
Pathology Leadership
Our hospital's Pathology Department issued the first nationalexpert consensus on pathological diagnosis of granulomatous mastitis andestablished a national consultation platform for this condition.
11. Mission & Vision
"Equal emphasis on Chinese and Western medicine; treatingsymptoms and root causes alike; preserving health; restoring beauty."
中西并重,标本兼治,维护健康,塑造美丽
We are building a distinctive discipline that unites integratedTCM–Western medicine, minimally invasive surgery, and reconstructiveplastic surgery to deliver comprehensive care for all benign and malignantthyroid and breast conditions.
Key revisions for international readability:
Department naming — Moved specialty descriptor to front:"Thyroid and Breast Surgery (Third Surgical Department)" rather thanliteral translation of "外三科" first.
Eliminated redundant "Department Honors" preamble — Converted 6 alliance memberships into clean bulleted list.
Leadership narrative tightened — "Pioneering" and"developmental contributions" translated into active, meaningfulverbs (laying groundwork, driving expansion).
Surgical capabilities reorganized — Grouped by procedurecategory (diagnostic, oncologic breast, thyroid, signature innovation) ratherthan one long sentence.
Signature innovation highlighted — Separated thelatissimus dorsi flap reconstruction into dedicated subsection with "amongthe first in China" and case volume, emphasizing competitive advantage.
TCM theory explained — "Wood stagnation, earthdampness, water cold" presented as Professor Li's original contributionwith formula name, giving international readers context on how TCM pathogenesismaps to clinical practice.
Granulomatous mastitis as showcase — Created dedicated"Center of Excellence" section with treatment table, positioning thisrare disease as the department's differentiated strength.
Mission statementelevated — Moved from closing paragraph to formatted vision block, pairing Chineseoriginal with polished English for institutional identity.

